Bausch + Lomb Corporation (TSX:BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. introduction of PreserVision® AREDS 2 Formula mini soft gels with OCUSorb™. This product is the only AREDS 2 eye vitamin with the OCUSorb formulation. Offering a proprietary composition of lutein and zeaxanthin, OCUSorb has been clinically shown to provide superior absorption of these nutrients into the body as compared to the original PreserVision AREDS 2 mini soft gel formula.
$100 Invested In This Stock 20 Years Ago Would Be Worth $700 Today
Vale (NYSE:VALE) has outperformed the market over the past 20 years by 2.51% on an annualized basis producing an average annual return of 9.99%. Currently, Vale has a market capitalization of $65.12 billion.
